Terms: = Skin cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Treatment
162 results:
1. The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma.
Bai J; Li X; Wen Y; Lu Q; Chen R; Liu R; Shangguan T; Ye Y; Lin J; Cai W; Kang D; Chen J
Aging (Albany NY); 2024 Feb; 16(4):3631-3646. PubMed ID: 38376408
[TBL] [Abstract] [Full Text] [Related]
2. Secondary malignancies among mantle cell lymphoma patients.
Abalo KD; Smedby KE; Ekberg S; Eloranta S; Pahnke S; Albertsson-Lindblad A; Jerkeman M; Glimelius I
Eur J Cancer; 2023 Dec; 195():113403. PubMed ID: 37952281
[TBL] [Abstract] [Full Text] [Related]
3. Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma.
Yamshon S; Chen GZ; Gribbin C; Christos P; Shah B; Schuster SJ; Smith SM; Svoboda J; Furman RR; Leonard JP; Martin P; Ruan J
Blood Adv; 2023 Nov; 7(21):6579-6588. PubMed ID: 37682791
[TBL] [Abstract] [Full Text] [Related]
4. Henoch-Schonlein Purpura, an Unusual Presentation of Acute Myeloid Leukemia.
Butt MA; Aamer S; Kapetanos A
Anticancer Res; 2023 Aug; 43(8):3579-3582. PubMed ID: 37500160
[TBL] [Abstract] [Full Text] [Related]
5. Combined mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma.
Glinkina KA; Teunisse AFAS; Gelmi MC; de Vries J; Jager MJ; Jochemsen AG
Melanoma Res; 2023 Oct; 33(5):345-356. PubMed ID: 37467061
[TBL] [Abstract] [Full Text] [Related]
6. Bcl-2 family inhibitors sensitize human cancer models to therapy.
Valentini E; Di Martile M; Brignone M; Di Caprio M; Manni I; Chiappa M; Sergio I; Chiacchiarini M; Bazzichetto C; Conciatori F; D'Aguanno S; D'Angelo C; Ragno R; Russillo M; Colotti G; Marchesi F; Bellone ML; Dal Piaz F; Felli MP; Damia G; Del Bufalo D
Cell Death Dis; 2023 Jul; 14(7):441. PubMed ID: 37460459
[TBL] [Abstract] [Full Text] [Related]
7. Advanced fumarate hydratase-deficient renal cell carcinoma responding to combination immune checkpoint inhibitors.
Howells E; Wigston L; Mackie G; Tran B; Nott L
Can J Urol; 2023 Jun; 30(3):11558-11561. PubMed ID: 37344468
[TBL] [Abstract] [Full Text] [Related]
8. Ponicidin Induces Apoptosis of Murine Melanoma by Inhibiting the NF-κB Signaling Pathway.
Wang L; Lou X; Wang D; Lu K; Zhang S; Cheng B
Biol Pharm Bull; 2023; 46(6):803-810. PubMed ID: 37258145
[TBL] [Abstract] [Full Text] [Related]
9. FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney cancer.
Wilde BR; Chakraborty N; Matulionis N; Hernandez S; Ueno D; Gee ME; Esplin ED; Ouyang K; Nykamp K; Shuch B; Christofk HR
Cancer Discov; 2023 Sep; 13(9):2072-2089. PubMed ID: 37255402
[TBL] [Abstract] [Full Text] [Related]
10. Survival Mechanisms of Metastatic Melanoma Cells: The Link between Glucocorticoids and the Nrf2-Dependent Antioxidant Defense System.
Obrador E; Salvador-Palmer R; López-Blanch R; Oriol-Caballo M; Moreno-Murciano P; Estrela JM
Cells; 2023 Jan; 12(3):. PubMed ID: 36766760
[TBL] [Abstract] [Full Text] [Related]
11. IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics.
Ming Z; Lim SY; Stewart A; Pedersen B; Shklovskaya E; Menzies AM; Carlino MS; Kefford RF; Lee JH; Scolyer RA; Long GV; Rizos H
J Invest Dermatol; 2023 Jul; 143(7):1246-1256.e8. PubMed ID: 36736995
[TBL] [Abstract] [Full Text] [Related]
12. Sensitivity of Cutaneous T-Cell Lymphoma Cells to the mcl-1 Inhibitor S63845 Correlates with the Lack of Bcl-w Expression.
Sumarni U; Zhu J; Sinnberg T; Eberle J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293331
[TBL] [Abstract] [Full Text] [Related]
13. LS-007 inhibits melanoma growth via inducing apoptosis and cell cycle arrest and regulating macrophage polarization.
Yin L; Liu X; Wu J; Yang J; Wang J; Dou H; Hou Y
Melanoma Res; 2022 Dec; 32(6):419-427. PubMed ID: 36094494
[TBL] [Abstract] [Full Text] [Related]
14. ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation.
Castro MV; Barbero GA; Máscolo P; Ramos R; Quezada MJ; Lopez-Bergami P
Cell Mol Biol Lett; 2022 Mar; 27(1):23. PubMed ID: 35260073
[TBL] [Abstract] [Full Text] [Related]
15. Cyst(e)inase-Rapamycin Combination Induces Ferroptosis in Both In Vitro and In Vivo Models of Hereditary Leiomyomatosis and Renal Cell cancer.
Kerimoglu B; Lamb C; McPherson RD; Ergen E; Stone EM; Ooi A
Mol Cancer Ther; 2022 Mar; 21(3):419-426. PubMed ID: 35086957
[TBL] [Abstract] [Full Text] [Related]
16. Lucanthone, Autophagy Inhibitor, Enhances the Apoptotic Effects of TRAIL through miR-216a-5p-Mediated DR5 Upregulation and DUB3-Mediated mcl-1 Downregulation.
Yoon JY; Woo SM; Seo SU; Song SR; Lee SG; Kwon TK
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008442
[TBL] [Abstract] [Full Text] [Related]
17. Bendamustine-induced rash is associated with a favorable prognosis in patients with indolent B-cell lymphoma.
Takahashi N; Tsukasaki K; Tanae K; Kohri M; Asou C; Okamura D; Ishikawa M; Maeda T; Kawai N; Matsuda A; Sato T; Kayano H; Arai E; Asou N
J Clin Exp Hematop; 2022 Mar; 62(1):18-24. PubMed ID: 34980789
[TBL] [Abstract] [Full Text] [Related]
18. Apoptotic stress-induced FGF signalling promotes non-cell autonomous resistance to cell death.
Bock FJ; Sedov E; Koren E; Koessinger AL; Cloix C; Zerbst D; Athineos D; Anand J; Campbell KJ; Blyth K; Fuchs Y; Tait SWG
Nat Commun; 2021 Nov; 12(1):6572. PubMed ID: 34772930
[TBL] [Abstract] [Full Text] [Related]
19. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.
Apostolidis SA; Kakara M; Painter MM; Goel RR; Mathew D; Lenzi K; Rezk A; Patterson KR; Espinoza DA; Kadri JC; Markowitz DM; E Markowitz C; Mexhitaj I; Jacobs D; Babb A; Betts MR; Prak ETL; Weiskopf D; Grifoni A; Lundgreen KA; Gouma S; Sette A; Bates P; Hensley SE; Greenplate AR; Wherry EJ; Li R; Bar-Or A
Nat Med; 2021 Nov; 27(11):1990-2001. PubMed ID: 34522051
[TBL] [Abstract] [Full Text] [Related]
20. Uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (hlrcc) syndrome can be identified through distinct clinical characteristics and typical morphology.
Uimari O; Ahtikoski A; Kämpjärvi K; Butzow R; Järvelä IY; Ryynänen M; Aaltonen LA; Vahteristo P; Kuismin O
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2066-2075. PubMed ID: 34480341
[TBL] [Abstract] [Full Text] [Related]
[Next]
